Triazine derivative, nucleating agent composition, resin composition, molded article, method for producing resin composition, and method for improving crystallinity of crystalline resin

Abstract

To provide: a novel triazine derivative; and a nucleating agent composition, a resin composition, a molded article, a method for producing the resin composition, and a method for improving the crystallinity of a crystalline resin using the derivative.SOLUTION: The triazine derivative is represented by the general formula (1) or general formula (2). (In the general formulas (1) and (2), X1 to X4 each represent a substituted or unsubstituted aryl group or the like, and Y1 represents a substituted or unsubstituted arylene group or the like.)SELECTED DRAWING: None

Description

[Technical Field]

[0001] The present invention relates to a triazine derivative, a nucleating agent composition, a resin composition, a molded article, a method for producing a resin composition, and a method for improving the crystallinity of a crystalline resin. [Background technology]

[0002] Various compounds have been investigated as additives for synthetic resins. For example, Patent Document 1 below discloses a compound having a triazine skeleton as an additive for synthetic resins. [Prior art documents] [Patent documents]

[0003] [Patent Document 1] Japanese Unexamined Patent Publication No. 54-4950 Summary of the Invention [Problem to be solved by the invention]

[0004] An object of the present invention is to provide a novel triazine derivative, a nucleating agent composition, a resin composition, a molded article, a method for producing a resin composition, and a method for improving the crystallinity of a crystalline resin, all of which use the same. [Means for solving the problem]

[0005] The present invention relates to a triazine derivative represented by the following general formula (1). JPEG2025160482000001.jpg27147 (In general formula (1), X1, X2, and X3 each independently represent a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, a substituted or unsubstituted arylamino group, or a substituted or unsubstituted arylthio group.)

[0006] The present invention also provides a triazine derivative represented by the following general formula (2) or (3). JPEG2025160482000002.jpg27147 (In general formula (2), X4 represents a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, a substituted or unsubstituted arylamino group, or a substituted or unsubstituted arylthio group, and Y1 represents a substituted or unsubstituted arylene group, a substituted or unsubstituted arylene dialkylene group, a substituted or unsubstituted arylene diamino group, or a substituted or unsubstituted arylene dithio group.) JPEG2025160482000003.jpg24147 (In general formula (3), X5 and X6 each independently represent a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, a substituted or unsubstituted arylamino group, or a substituted or unsubstituted arylthio group; and Y2 represents a substituted or unsubstituted arylene group, a substituted or unsubstituted arylene dialkylene group, a substituted or unsubstituted arylene diamino group, or a substituted or unsubstituted arylene dithio group.)

[0007] Furthermore, the present invention relates to a nucleating agent composition containing the above triazine derivative.

[0008] Furthermore, the present invention is a resin composition containing a crystalline resin and the above-mentioned triazine derivative.

[0009] The present invention also relates to a molded article obtained by molding the above-described resin composition.

[0010] Furthermore, the present invention provides a method for producing a resin composition, which comprises a compounding step of mixing a crystalline resin with the above-mentioned triazine derivative.

[0011] Furthermore, the present invention is a method for improving the crystallinity of a crystalline resin, which comprises a blending step of mixing a crystalline resin with the above-mentioned compound. [Effects of the Invention]

[0012] According to the present invention, it is possible to provide a novel triazine derivative, a nucleating agent composition containing this triazine derivative, a resin composition, a molded article, a method for producing a resin composition, and a method for improving the crystallinity of a crystalline resin. DETAILED DESCRIPTION OF THE INVENTION

[0013] Hereinafter, embodiments of the present invention will be described in detail. <Triazine derivatives> First, the triazine derivative of this embodiment will be described.

[0014] Among the triazine derivatives of this embodiment, the triazine derivative of the first embodiment is represented by the following general formula (1).

[0015] JPEG2025160482000004.jpg27147

[0016] In general formula (1), X1, X2, and X3 each independently represent a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, a substituted or unsubstituted arylamino group, or a substituted or unsubstituted arylthio group.

[0017] The triazine derivative of the first embodiment can be used as a synthetic resin additive or an oil additive, such as a nucleating agent for polyolefin resins (e.g., polyethylene resins, polypropylene resins), a nucleating agent for polyamide resins, a nucleating agent for polyester resins, a nucleating agent for polyacetal, a nucleating agent for polylactic acid, or a nucleating agent for polyphenylene sulfide, an antioxidant, an ultraviolet absorber, a thickener, a filler, a conductive agent, an anti-wear agent, a light stabilizer, or a metal deactivator (copper inhibitor). The triazine derivative of the first embodiment can be suitably used as a nucleating agent for crystalline resins (e.g., polyolefin resins, polyamide resins, polyester resins, polyacetal, polylactic acid, or polyphenylene sulfide), more suitably used as a nucleating agent for polyolefin resins, and particularly suitably used as a nucleating agent for polypropylene resins. The triazine derivative of the first embodiment can also be suitably used as a nucleating agent for polyethylene resins.

[0018] Examples of the aryl group represented by X1 to X3 include a phenyl group, a biphenyl group, a naphthyl group, and an anthryl group.

[0019] Examples of the arylalkyl group represented by X1 to X3 include a phenylmethyl group, a biphenylmethyl group, a naphthylmethyl group, an anthrylmethyl group, a phenylethyl group, a biphenylethyl group, a naphthylethyl group, an anthrylethyl group, a 2-phenyl-2-propyl group, a 2-biphenyl-2-propyl group, a 2-naphthyl-2-propyl group, and a 2-anthryl-2-propyl group.

[0020] Examples of the arylamino group represented by X1 to X3 include a phenylamino group, a biphenylamino group, a naphthylamino group, and an anthrylamino group.

[0021] Examples of the arylthio group represented by X1 to X3 include a phenylthio group, a biphenylthio group, a naphthylthio group, and an anthrylthio group.

[0022] When the aryl group, arylamino group or arylthio group represented by X1 to X3 has a substituent, examples of the substituent include a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom or an iodine atom, a hydroxyl group, an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, an alkylcarbonyl group having 1 to 10 carbon atoms, an alkoxycarbonyl group having 1 to 10 carbon atoms, an aminocarbonyl group and a carboxy group.

[0023] In the triazine derivative of the first embodiment, from the viewpoint of improving the performance as a nucleating agent for a crystalline resin, X1, X2, and X3 are preferably substituted or unsubstituted aryl groups or substituted or unsubstituted arylalkyl groups, more preferably substituted or unsubstituted aryl groups, even more preferably substituted or unsubstituted phenyl groups, and even more preferably unsubstituted phenyl groups. Note that, from the viewpoint of improving the performance as a nucleating agent for a crystalline resin, in the triazine derivative of the first embodiment, X1, X2, and X3 may be substituted or unsubstituted arylalkyl groups, more preferably substituted or unsubstituted phenylmethyl groups, and even more preferably unsubstituted phenylmethyl groups.

[0024] In addition, in the triazine derivative of the first embodiment, from the viewpoint of improving the performance as a nucleating agent for a crystalline resin, X1, X2, and X3 are also preferably substituted or unsubstituted arylamino groups, more preferably substituted or unsubstituted phenylamino groups, and even more preferably unsubstituted phenylamino groups.

[0025] Furthermore, in the triazine derivative of the first embodiment, from the viewpoint of improving the performance as a nucleating agent for a crystalline resin, X1, X2, and X3 are also preferably substituted or unsubstituted arylthio groups, more preferably substituted or unsubstituted phenylthio groups, and even more preferably unsubstituted phenylthio groups.

[0026] Specific examples of the triazine derivative represented by general formula (1) include Compounds 1-1 to 1-51, in which X1, X2, and X3 in general formula (1) are groups shown in Tables 1-1 and 1-2 below, although the triazine derivative of the first embodiment is not limited thereto.

[0027] [Table 1-1]

[0028] [Table 1-2]

[0029] The triazine derivative of the first embodiment can be produced by an appropriate combination of methods such as a method of reacting an arylamine or an arylthiol with cyanuric chloride under basic conditions, and a method of reacting an aromatic hydrocarbon derivative with cyanuric chloride via the Friedel-Crafts reaction in the presence of a Lewis acid catalyst.

[0030] Among the triazine derivatives of this embodiment, the triazine derivative of the second embodiment is represented by the following general formula (2) or the following general formula (3).

[0031] JPEG2025160482000007.jpg27147

[0032] Here, in general formula (2), X4 represents a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, a substituted or unsubstituted arylamino group, or a substituted or unsubstituted arylthio group, and Y1 represents a substituted or unsubstituted arylene group, a substituted or unsubstituted arylene dialkylene group, a substituted or unsubstituted arylene diamino group, or a substituted or unsubstituted arylene dithio group.

[0033] JPEG2025160482000008.jpg24147

[0034] In general formula (3), X5 and X6 each independently represent a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, a substituted or unsubstituted arylamino group, or a substituted or unsubstituted arylthio group, and Y2 represents a substituted or unsubstituted arylene group, a substituted or unsubstituted arylene dialkylene group, a substituted or unsubstituted arylene diamino group, or a substituted or unsubstituted arylene dithio group.

[0035] The triazine derivative of the second embodiment can be used as a synthetic resin additive or oil additive, such as a nucleating agent for polyolefin resins (e.g., polyethylene resins, polypropylene resins), a nucleating agent for polyamide resins, a nucleating agent for polyester resins, a nucleating agent for polyacetal, a nucleating agent for polylactic acid, or a nucleating agent for polyphenylene sulfide, an antioxidant, an ultraviolet absorber, a thickener, a filler, a conductive agent, an anti-wear agent, a light stabilizer, or a metal deactivator (copper inhibitor). The triazine derivative of the second embodiment can be suitably used as a nucleating agent for crystalline resins (e.g., polyolefin resins, polyamide resins, polyester resins, polyacetal, polylactic acid, or polyphenylene sulfide), more suitably used as a nucleating agent for polyolefin resins, and particularly suitably used as a nucleating agent for polypropylene resins. The triazine derivative of the second embodiment can also be suitably used as a nucleating agent for polyethylene resins.

[0036] Examples of the aryl group, arylalkyl group, arylamino group and arylthio group represented by X4 to X6 include the same groups as those exemplified as the aryl group, arylalkyl group, arylamino group and arylthio group represented by X1 to X3.

[0037] When the aryl group, arylamino group, and arylthio group represented by X4 to X6 have a substituent, examples of the substituent include the same as those exemplified as the substituent when the aryl group, arylamino group, and arylthio group represented by X1 to X3 have a substituent.

[0038] Examples of the arylene group represented by Y1 and Y2 include a phenylene group, a biphenylylene group, a naphthylylene group, and an anthrylene group.

[0039] Examples of the arylene dialkylene group represented by Y1 and Y2 include a phenylenedimethylene group, a biphenylenedimethylene group, a naphthylenediethylene group, an anthrylenediethylene group, a phenylenediethylene group, a biphenylenediethylene group, a naphthylenediethylene group, and an anthrylenediethylene group.

[0040] Examples of the arylene diamino group represented by Y1 and Y2 include a phenylenediamino group, a biphenylenediamino group, a naphthylenediamino group, and an anthrylene diamino group.

[0041] Examples of the arylenedithio group represented by Y1 and Y2 include a phenylenedithio group, a biphenylenedithio group, a naphthylenedithio group, and anthrylenedithio group.

[0042] When the arylene group, arylene diamino group, or arylene dithio group represented by Y1 and Y2 has a substituent, examples of the substituent include the same as those described above as the substituent when the aryl group, arylamino group, or arylthio group represented by X1 to X3 has a substituent.

[0043] In the triazine derivative of the second embodiment, from the viewpoint of improving the performance as a nucleating agent for a crystalline resin, it is preferable that X4 is a substituted or unsubstituted aryl group or a substituted or unsubstituted arylalkyl group, Y1 is a substituted or unsubstituted arylene group or a substituted or unsubstituted arylene dialkylene group, X5 and X6 are each independently a substituted or unsubstituted aryl group or a substituted or unsubstituted arylalkyl group, and Y2 is a substituted or unsubstituted arylene group or a substituted or unsubstituted arylene dialkylene group. That is, it is preferable that X4 to X6 are substituted or unsubstituted aryl groups or substituted or unsubstituted arylalkyl groups, and Y1 and Y2 are substituted or unsubstituted arylene groups or substituted or unsubstituted arylene dialkylene groups.

[0044] From the viewpoint of further improving the performance as a nucleating agent for a crystalline resin, it is preferable that X4 to X6 are substituted or unsubstituted aryl groups and Y1 and Y2 are substituted or unsubstituted arylene groups, it is more preferable that X4 to X6 are substituted or unsubstituted phenyl groups and Y1 and Y2 are substituted or unsubstituted phenylene groups, and it is even more preferable that X4 to X6 are unsubstituted phenyl groups and Y1 and Y2 are unsubstituted phenylene groups.

[0045] Furthermore, from the viewpoint of further improving the performance as a nucleating agent for a crystalline resin, X4 to X6 may be a substituted or unsubstituted arylalkyl group and Y1 and Y2 may be a substituted or unsubstituted arylene dialkylene group, more preferably X4 to X6 are a substituted or unsubstituted phenylmethyl group and Y1 and Y2 are substituted or unsubstituted phenylenedimethylene groups, and even more preferably X4 to X6 are unsubstituted phenyl groups and Y1 and Y2 are unsubstituted phenylenedimethylene groups.

[0046] In the triazine derivative of the second embodiment, from the viewpoint of further improving the performance as a nucleating agent for a crystalline resin, it is also preferable that X4 is a substituted or unsubstituted arylamino group, Y1 is a substituted or unsubstituted arylene diamino group, X5 and X6 are each independently a substituted or unsubstituted arylamino group, and Y2 is a substituted or unsubstituted arylene diamino group. That is, it is also preferable that X4 to X6 are substituted or unsubstituted arylamino groups, and Y1 and Y2 are substituted or unsubstituted arylene diamino groups. From the viewpoint of further improving the performance as a nucleating agent for a crystalline resin, it is preferable that X4 to X6 are substituted or unsubstituted phenylamino groups, and Y1 and Y2 are substituted or unsubstituted phenylenediamino groups, and it is more preferable that X4 to X6 are unsubstituted phenylamino groups, and Y1 and Y2 are unsubstituted phenylenediamino groups.

[0047] Furthermore, in the triazine derivative of the second embodiment, from the viewpoint of further improving the performance as a nucleating agent for a crystalline resin, it is also preferable that X4 is a substituted or unsubstituted arylthio group, Y1 is a substituted or unsubstituted arylenedithio group, X5 and X6 are each independently a substituted or unsubstituted arylthio group, and Y2 is a substituted or unsubstituted arylenedithio group. That is, it is also preferable that X4 to X6 are substituted or unsubstituted arylthio groups and Y1 and Y2 are substituted or unsubstituted arylenedithio groups. From the viewpoint of further improving the performance as a nucleating agent for a crystalline resin, it is preferable that X4 to X6 are substituted or unsubstituted phenylthio groups and Y1 and Y2 are substituted or unsubstituted phenylenedithio groups, and it is more preferable that X4 to X6 are unsubstituted phenylthio groups and Y1 and Y2 are unsubstituted phenylenedithio groups.

[0048] Specific examples of the triazine derivative represented by general formula (2) include Compounds 2-1 to 2-138 in which X4 and Y1 in general formula (2) are groups shown in Tables 2-1 to 2-3 below, although the triazine derivative of the second embodiment is not limited thereto.

[0049] [Table 2-1]

[0050] [Table 2-2]

[0051] [Table 2-3]

[0052] Specific examples of the triazine derivative represented by general formula (3) include compounds 3-1 to 3-12 in which X5, X6, and Y2 in general formula (3) are groups shown in the following Table 3. However, the triazine derivative of the second embodiment is not limited to these.

[0053] [Table 3]

[0054] The triazine derivative of the second embodiment can be produced by an appropriate combination of methods such as a method of reacting an arylamine, an arylthiol, an arylenediamine, or an arylenedithiol with cyanuric chloride under basic conditions, and a method of reacting an aromatic hydrocarbon derivative with cyanuric chloride via the Friedel-Crafts reaction in the presence of a Lewis acid catalyst.

[0055] Next, the nucleating agent composition of this embodiment will be described. <Nucleating agent composition> The nucleating agent composition of the present embodiment includes the triazine derivative described above. The nucleating agent composition of the present embodiment can improve the crystallinity of the crystalline resin.

[0056] The nucleating agent composition of this embodiment can be suitably used for crystalline resins, and is preferably for polyolefin-based resins, and more preferably for polypropylene-based resins. The nucleating agent composition of this embodiment may also be for polyethylene-based resins. Furthermore, the nucleating agent composition of this embodiment may be for polyamide-based resins, polyester-based resins, polyacetal resins, polylactic acid, or polyphenylene sulfide, and is preferably for polyamide-based resins or polyester-based resins, and more preferably for polyamide-based resins. Furthermore, the nucleating agent composition of this embodiment may also be for polyester-based resins, which are crystalline resins.

[0057] The nucleating agent composition of this embodiment may contain only one type of triazine derivative, or may contain two or more types. When the nucleating agent composition of this embodiment contains two or more types of triazine derivatives, the triazine derivative with the highest content contained therein is defined as the "main component." The content of the main component relative to the total triazine derivatives can be, for example, 10 to 99.9 mass%. The content of the main component relative to the total triazine derivatives is preferably 50 to 99 mass%, more preferably 80 to 95 mass%. When the nucleating agent composition of this embodiment contains two or more types of triazine derivatives, the triazine derivatives contained in the nucleating agent composition other than the main component are defined as "minor components." The total content of the minor components relative to the total triazine derivatives can be, for example, 0.1 to 90 mass%, preferably 1 to 50 mass%, more preferably 5 to 20 mass%. The nucleating agent composition of this embodiment may consist solely of a triazine derivative, or may consist solely of one type of triazine derivative.

[0058] The nucleating agent composition of the present embodiment preferably further contains a colorant. Examples of the colorant include pigment red 1, 2, 3, 9, 10, 17, 22, 23, 31, 38, 41, 48, 49, 88, 90, 97, 112, 119, 122, 123, 144, 149, 166, 168, 169, 170, 171, 177, 179, 180, 184, 185, 192, 200, 202, 209, 215, 216, 217, 220, 223, 224, 226, 227, 228, 240, 254; red pigments such as Pigment Orange 13, 31, 34, 36, 38, 43, 46, 48, 49, 51, 52, 55, 59, 60, 61, 62, 64, 65, 71; Pigment Yellow 1, 3, 12, 13, 14, 16, 17, 20, 24, 55, 60, 73, 81, 83, 86, 93, 95, 97, 98, 100, 109, 110, 113, 114, 117, 120, 125, 126, 127, 129, 13 Yellow pigments such as Pigment 7, 138, 139, 147, 148, 150, 151, 152, 153, 154, 166, 168, 175, 180, 185; green pigments such as Pigment Green 7, 10, 36; blue pigments such as Pigment Blue 15, 15:1, 15:2, 15:3, 15:4, 15:5, 15:6, 22, 24, 27, 29, 56, 60, 61, 62, 64; Pigment Violet 1, 15, 19, 23, 2 Examples of suitable dyes include purple pigments such as Pigment Blue 7, 29, 30, 32, 37, 40, and 50, azo dyes, anthraquinone dyes, indigoid dyes, triarylmethane dyes, xanthene dyes, alizarin dyes, acridine dyes, stilbene dyes, thiazole dyes, naphthol dyes, quinoline dyes, nitro dyes, indamine dyes, oxazine dyes, phthalocyanine dyes, cyanine dyes, Acid Blue 74, and Acid Blue 9. Among these, green pigments, blue pigments, and purple pigments are preferred, blue pigments and purple pigments are more preferred, blue pigments are even more preferred, and Pigment Blue 27 or Pigment Blue 29 are even more preferred, with Pigment Blue 29 being particularly preferred. It is also preferred that the colorant be Acid Blue 74, Acid Blue 9, or Pigment Violet 15.When the nucleating agent composition of the present embodiment contains a colorant, the content of the colorant can be, for example, 0.01 to 5 parts by mass, preferably 0.1 to 2 parts by mass, more preferably 0.3 to 1.5 parts by mass, and even more preferably 0.5 to 1 part by mass, relative to 100 parts by mass of the triazine derivative.

[0059] The nucleating agent composition of the present embodiment may further contain one or more nucleating agents other than the triazine derivatives (hereinafter referred to as "other nucleating agents"), as well as additives such as phenolic antioxidants, phosphorus-based antioxidants, sulfur-based antioxidants, other antioxidants, hindered amine compounds, ultraviolet absorbers, fatty acid metal salts, flame retardants, flame retardant aids, fillers, lubricants, hydrotalcites, antistatic agents, and fluorescent brighteners, other than the triazine derivatives (hereinafter referred to as "other additives").

[0060] Other nucleating agents include, for example, aromatic phosphate metal salts such as sodium 2,2'-methylenebis(4,6-di-tert-butylphenyl)phosphate, lithium 2,2'-methylenebis(4,6-di-tert-butylphenyl)phosphate, dihydroxyaluminum 2,2'-methylenebis(4,6-di-tert-butylphenyl)phosphate, and hydroxyaluminum bis[2,2'-methylenebis(4,6-di-tert-butylphenyl)phosphate], sodium benzoate, aluminum 4-tert-butylbenzoate, sodium adipate, disodium bicyclo[2.2.1]heptane-2,3-dicarboxylate, and calcium Examples of the compound include metal salts of carboxylic acids such as cyclohexane-1,2-dicarboxylate, amide compounds such as N,N',N"-tris[2-methylcyclohexyl]-1,2,3-propanetricarboxamide, N,N',N"-tricyclohexyl-1,3,5-benzenetricarboxamide, N,N'-dicyclohexylnaphthalenedicarboxamide, and 1,3,5-tris[(2,2-dimethylpropanoylamino)]benzene, and diacetal compounds such as dibenzylidene sorbitol, bis(p-methylbenzylidene)sorbitol, bis(p-ethylbenzylidene)sorbitol, bis(3,4-dimethylbenzylidene)sorbitol, and 1,2,3-trideoxy-4,6:5,7-o-bis(4-propylbenzylidene)nonitol.

[0061] Examples of phenolic antioxidants include 2,6-di-tert-butyl-4-ethylphenol, 2-tert-butyl-4,6-dimethylphenol, styrenated phenol, 2,2'-methylenebis(4-ethyl-6-tert-butylphenol), 2,2'-thiobis-(6-tert-butyl-4-methylphenol), 2,2'-thiodiethylenebis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate], 2-methyl-4,6-bis(octylsulfanylmethyl)phenol, 2,2'-isobutylidenebis(4,6-dimethylphenol), isooctyl-3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate, and 2,2'-isobutylidenebis(4,6-dimethylphenol). Nyl)propionate, N,N'-hexane-1,6-diylbis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionamide], 2,2'-oxamido-bis[ethyl-3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate], 2-ethylhexyl-3-(3',5'-di-tert-butyl-4'-hydroxyphenyl)propionate, 2,2'-ethylenebis(4,6-di-tert-butylphenol), 3,5-di-tert-butyl-4-hydroxybenzenepropanoic acid and C13-15 alkyl ester, 2,5-di-tert-amylhydroquinone, hindered phenol polymer (ADEKA POLYMER ADDITIVES EUROPE SAS) Trade name "AO.OH.98"), 2,2'-methylenebis[6-(1-methylcyclohexyl)-p-cresol], 2-tert-butyl-6-(3-tert-butyl-2-hydroxy5-methylbenzyl)-4-methylphenyl acrylate, 2-[1-(2-hydroxy-3,5-di-tert-pentylphenyl)ethyl]-4,6-di-tert-pentylphenyl acrylate, 6-[3-(3-tert-butyl-4-hydroxy-5-methyl)propoxy]-2,4,8,10-tetra-tert-butylbenz[d,f][1,3,2]-dioxaphophobin, hexamethylenebis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate], bis[monoethyl(3,5-di-tert-butyl-4-hydroxybenzyl)phosphonate]calcium salt, 5,Reaction products of 7-bis(1,1-dimethylethyl)-3-hydroxy-2(3H)-benzofuranone with o-xylene, 2,6-di-tert-butyl-4-(4,6-bis(octylthio)-1,3,5-triazin-2-ylamino)phenol, DL-α-tocophenol (vitamin E), 2,6-bis(α-methylbenzyl)-4-methylphenol, bis[3,3-bis-(4'-hydroxy-3'-tert-butyl-phenyl)butanoic acid] glycol ester, 2,6-di-tert-butyl-p-cresol, 2,6-diphenyl Nyl-4-octadecyloxyphenol, stearyl (3,5-di-tert-butyl-4-hydroxyphenyl)propionate, distearyl (3,5-di-tert-butyl-4-hydroxybenzyl)phosphonate, tridecyl-3,5-tert-butyl-4-hydroxybenzylthioacetate, thiodiethylenebis[(3,5-di-tert-butyl-4-hydroxyphenyl)propionate], 4,4'-thiobis(6-tert-butyl-m-cresol), 2-octylthio-4,6-di(3,5-di-tert-butyl) (4-hydroxyphenoxy)-s-triazine, 2,2'-methylenebis(4-methyl-6-tert-butylphenol), bis[3,3-bis(4-hydroxy-3-tert-butylphenyl)butylic acid] glycol ester, 4,4'-butylidenebis(2,6-di-tert-butylphenol), 4,4'-butylidenebis(6-tert-butyl-3-methylphenol), 2,2'-ethylidenebis(4,6-di-tert-butylphenol), 1,1,3-tris(2-methyl-4-hydroxy-5-tert-butylphenol), rt-butylphenyl)butane, bis[2-tert-butyl-4-methyl-6-(2-hydroxy-3-tert-butyl-5-methylbenzyl)phenyl]terephthalate, 1,3,5-tris(2,6-dimethyl-3-hydroxy-4-tert-butylbenzyl)isocyanurate, 1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)isocyanurate, 1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)-2,4,6-trimethylbenzene, 1,3,5-tris[(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxyethyl]isocyanurate, tetrakis[methylene-3-(3',5'-tert-butyl-4'-hydroxyphenyl)propionate]methane, 2-tert-butyl-4-methyl-6-(2-acryloyloxy-3-tert-butyl-5-methylbenzyl)phenol, 3,9-bis[2-(3-tert-butyl-4-hydroxy-5-methylhydrocinnamoyloxy)-1,1-dimethylethyl]-2,4,8,10-tetraoxaspiro[5.5]undecane, triethylene glycol bis[β 3-(3,5-dialkyl-4-hydroxyphenyl)propionic acid derivatives such as 3-(3,5-di-tert-butyl-4-hydroxy-5-methylphenyl)propionate, stearyl-3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionic acid amide, palmityl-3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionic acid amide, myristyl-3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionic acid amide, and lauryl-3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionic acid amide, etc.

[0062] Examples of phosphorus-based antioxidants include triphenyl phosphite, diisooctyl phosphite, heptakis(dipropylene glycol)triphosphite, triisodecyl phosphite, diphenyl isooctyl phosphite, diisooctylphenyl phosphite, diphenyl tridecyl phosphite, triisooctyl phosphite, trilauryl phosphite, diphenyl phosphite, tris(dipropylene glycol)phosphite, dioleylhydrogen phosphite, trilauryl trithiophosphite, and bis(tridecyl)phosphite. phosphite, tris(isodecyl)phosphite, tris(tridecyl)phosphite, diphenyldecylphosphite, dinonylphenylbis(nonylphenyl)phosphite, poly(dipropylene glycol)phenylphosphite, tetraphenyldipropylene glycol diphosphite, trisnonylphenylphosphite, tris(2,4-di-tert-butylphenyl)phosphite, tris(2,4-di-tert-butyl-5-methylphenyl)phosphite, tris[2-tert-butyl-4-(3-tert-butyl-4-hydrochloride] (tridecyl) bisphenol A phosphite, octyl diphenyl phosphite, di(decyl) monophenyl phosphite, mixture of distearyl pentaerythritol and calcium stearate, alkyl (C10) bisphenol A phosphite, tetraphenyl-tetra(tridecyl) pentaerythritol tetraphosphite, bis(2,4-di-tert-butyl-6-methylphenyl)ethyl phosphite, tetra(tridecyl) isopropylidenediphenol diphosphite tetra(tridecyl)-4,4'-n-butylidenebis(2-tert-butyl-5-methylphenol)diphosphite, hexa(tridecyl)-1,1,3-tris(2-methyl-4-hydroxy-5-tert-butylphenyl)butanetriphosphite, tetrakis(2,4-di-tert-butylphenyl)biphenylene diphosphonite, 9,10-dihydro-9-oxa-10-phosphaphenanthrene-10-oxide, (1-methyl-1-propenyl-3-ylidene)tris(1,1-dimethylethyl)-5-methyl-4,1-phenylene)hexatridecyl phosphite, 2,2'-methylenebis(4,6-di-tert-butylphenyl)-2-ethylhexyl phosphite, 2,2'-methylenebis(4,6-di-tert-butylphenyl)-octadecyl phosphite, 2,2'-ethylidenebis(4,6-di-tert-butylphenyl)fluorophosphite, 4,4'-butylidenebis(3-methyl- 6-tert-butylphenylditridecyl)phosphite, tris(2-[(2,4,8,10-tetrakis-tert-butyldibenzo[d,f][1,3,2]dioxaphosphepin-6-yl)oxy]ethyl)amine, 3,9-bis(4-nonylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphespiro[5,5]undecane, 2,4,6-tri-tert-butyl Examples of suitable phosphates include phenyl-2-butyl-2-ethyl-1,3-propanediol phosphite, poly4,4'-isopropylidenediphenol C12-15 alcohol phosphite, bis(diisodecyl)pentaerythritol diphosphite, bis(tridecyl)pentaerythritol diphosphite, bis(octadecyl)pentaerythritol diphosphite, bis(nonylphenyl)pentaerythritol diphosphite, bis(2,4-di-tert-butylphenyl)pentaerythritol diphosphite, bis(2,4,6-tri-tert-butylphenyl)pentaerythritol diphosphite, bis(2,6-di-tert-butyl-4-methylphenyl)pentaerythritol diphosphite, and bis(2,4-dicumylphenyl)pentaerythritol diphosphite.

[0063] Examples of sulfur-based antioxidants include tetrakis[methylene-3-(laurylthio)propionate]methane, bis(methyl-4-[3-n-alkyl(C12 / C14)thiopropionyloxy]5-tert-butylphenyl)sulfide, ditridecyl-3,3'-thiodipropionate, dilauryl-3,3'-thiodipropionate, dimyristyl-3,3'-thiodipropionate, distearyl-3,3'-thiodipropionate, lauryl / stearyl thiodipropionate, 4,4'-thiobis(6-tert-butyl-m-cresol), 2,2'-thiobis(6-tert-butyl-p-cresol), and distearyl disulfide.

[0064] Other antioxidants include nitrone compounds such as N-benzyl-α-phenyl nitrone, N-ethyl-α-methyl nitrone, N-octyl-α-heptyl nitrone, N-lauryl-α-undecyl nitrone, N-tetradecyl-α-tridecyl nitrone, N-hexadecyl-α-pentadecyl nitrone, N-octyl-α-heptadecyl nitrone, N-hexadecyl-α-heptadecyl nitrone, N-octadecyl-α-pentadecyl nitrone, N-heptadecyl-α-heptadecyl nitrone, and N-octadecyl-α-heptadecyl nitrone; 3-arylbenzofuran-2(3H)-one, 3-(alkoxyphenyl)benzofuran-2-one, 3-(acyloxyphenyl)benzofuran-2(3H)-one; Examples of the benzofuran compounds include t-butyl-3-(3,4-dimethylphenyl)-benzofuran-2(3H)-one, 5,7-di-tert-butyl-3-(4-hydroxyphenyl)-benzofuran-2(3H)-one, 5,7-di-tert-butyl-3-{4-(2-hydroxyethoxy)phenyl}-benzofuran-2(3H)-one, 6-(2-(4-(5,7-di-tert-2-oxo-2,3-dihydrobenzofuran-3-yl)phenoxy)ethoxy)-6-oxohexyl-6-((6-hydroxyhexanoyl)oxy)hexanoate, and 5-di-tert-butyl-3-(4-((15-hydroxy-3,6,9,13-tetraoxapentadecyl)oxy)phenyl)benzofuran-2(3H)-one.

[0065] Examples of the hindered amine compound include 2,2,6,6-tetramethyl-4-piperidyl stearate, 1,2,2,6,6-pentamethyl-4-piperidyl stearate, 2,2,6,6-tetramethyl-4-piperidyl benzoate, bis(2,2,6,6-tetramethyl-4-piperidyl)sebacate, tetrakis(2,2,6,6-tetramethyl-4-piperidyl)-1,2,3,4-butanetetracarboxylate, tetrakis(1,2,2,6,6-pentamethyl-4-piperidyl)-1,2,3,4-butanetetracarboxylate, biphenylsulfonyl ether ... Bis(2,2,6,6-tetramethyl-4-piperidyl)di(tridecyl)-1,2,3,4-butanetetracarboxylate, bis(1,2,2,6,6-pentamethyl-4-piperidyl)di(tridecyl)-1,2,3,4-butanetetracarboxylate, bis(1,2,2,4,4-pentamethyl-4-piperidyl)-2-butyl-2-(3,5-di-tert-butyl-4-hydroxybenzyl)malonate, 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-piperidinol / diethyl succinate polycondensate, 1,6-bis( 2,2,6,6-tetramethyl-4-piperidylamino)hexane / 2,4-dichloro-6-morpholino-s-triazine polycondensate, 1,6-bis(2,2,6,6-tetramethyl-4-piperidylamino)hexane / 2,4-dichloro-6-tert-octylamino-s-triazine polycondensate, 1,5,8,12-tetrakis[2,4-bis(N-butyl-N-(2,2,6,6-tetramethyl-4-piperidyl)amino)-s-triazine-6-yl]-1,5,8,12-tetraazadodecane, 1,5,8,12-tetrakis[2,4-bis(N- butyl-N-(1,2,2,6,6-pentamethyl-4-piperidyl)amino)-s-triazin-6-yl]-1,5,8-12-tetraazadodecane, 1,6,11-tris[2,4-bis(N-butyl-N-(2,2,6,6-tetramethyl-4-piperidyl)amino)-s-triazin-6-ylamino]undecane, 1,6,11-tris[2,4-bis(N-butyl-N-(1,2,2,6,6-pentamethyl-4-piperidyl)amino)-s-triazin-6-ylamino]undecane, 3,9-bis[1,1-dimethyl-2-{tris(2,Examples of suitable bis(1-undecyloxy-2,2,6,6-tetramethyl-4-piperidyloxycarbonyl)butylcarbonyloxy}ethyl)-2,4,8,10-tetraoxaspiro[5.5]undecane include 3,9-bis[1,1-dimethyl-2-{tris(1,2,2,6,6-pentamethyl-4-piperidyloxycarbonyl)butylcarbonyloxy}ethyl]-2,4,8,10-tetraoxaspiro[5.5]undecane, bis(1-undecyloxy-2,2,6,6-tetramethylpiperidin-4-yl)carbonate, 2,2,6,6-tetramethyl-4-piperidyl hexadecanoate, and 2,2,6,6-tetramethyl-4-piperidyl octadecanoate.

[0066] Examples of the ultraviolet absorber include 2-hydroxybenzophenones such as 2,4-dihydroxybenzophenone and 5,5'-methylenebis(2-hydroxy-4-methoxybenzophenone); 2-(2-hydroxy-5-methylphenyl)benzotriazole, 2-(2-hydroxy-5-tert-octylphenyl)benzotriazole, 2-(2-hydroxy-3,5-di-tert-butylphenyl)-5-chlorobenzotriazole, 2-(2-hydroxy-3-tert-butyl-5-methylphenyl)-5-chlorobenzotriazole, 2-( 2-Hydroxy-3,5-dicumylphenyl)benzotriazole, 2,2'-methylenebis(4-tert-octyl-6-benzotriazolylphenol), polyethylene glycol esters of 2-(2-hydroxy-3-tert-butyl-5-carboxyphenyl)benzotriazole, 2-[2-hydroxy-3-(2-acryloyloxyethyl)-5-methylphenyl]benzotriazole, 2-[2-hydroxy-3-(2-methacryloyloxyethyl)-5-tert-butylphenyl]benzotriazole, 2-[2-hydroxy- 3-(2-Methacryloyloxyethyl)-5-tert-octylphenyl]benzotriazole, 2-[2-hydroxy-3-(2-methacryloyloxyethyl)-5-tert-butylphenyl]-5-chlorobenzotriazole, 2-[2-hydroxy-5-(2-methacryloyloxyethyl)phenyl]benzotriazole, 2-[2-hydroxy-3-tert-butyl-5-(2-methacryloyloxyethyl)phenyl]benzotriazole, 2-[2-hydroxy-3-tert-amyl-5-(2-methacryloyloxyethyl) 2-(2-hydroxyphenyl)benzotriazoles such as 2-[2-hydroxy-3-tert-butyl-5-(3-methacryloyloxypropyl)phenyl]benzotriazole, 2-[2-hydroxy-4-(2-methacryloyloxymethyl)phenyl]benzotriazole, 2-[2-hydroxy-4-(3-methacryloyloxy-2-hydroxypropyl)phenyl]benzotriazole, and 2-[2-hydroxy-4-(3-methacryloyloxypropyl)phenyl]benzotriazole;Phenyl salicylate, resorcinol monobenzoate, 2,4-di-tert-butylphenyl-3,5-di-tert-butyl-4-hydroxybenzoate, octyl (3,5-di-tert-butyl-4-hydroxy)benzoate, dodecyl (3,5-di-tert-butyl-4-hydroxy)benzoate, tetradecyl (3,5-di-tert-butyl-4-hydroxy)benzoate, hexadecyl (3,5-di-tert-butyl-4-hydroxy)benzoate Benzoates such as octadecyl (3,5-di-tert-butyl-4-hydroxy) benzoate, behenyl (3,5-di-tert-butyl-4-hydroxy) benzoate; substituted oxanilides such as 2-ethyl-2'-ethoxyoxanilide, 2-ethoxy-4'-dodecyloxanilide; cyanoacrylates such as ethyl-α-cyano-β,β-diphenylacrylate, methyl-2-cyano-3-methyl-3-(p-methoxyphenyl)acrylate; 2-(4, 6-Diphenyl-1,3,5-triazin-2-yl)-5-hexyloxyphenol, 2-(2-hydroxy-4-octoxyphenyl)-4,6-bis(2,4-dimethylphenyl)-1,3,5-triazine, trioctyl-2,2',2"-((1,3,5-triazine-2,4,6-triyl)tris(3-hydroxybenzene-4-,1-diyl)tripropionate), 2-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-[2-(2-ethyl Examples of suitable amines include triazines (excluding the triazine derivative of the present embodiment described above) such as 2,4,6-tris(2-hydroxy-4-hexyloxy-3-methylphenyl)-1,3,5-triazine, 1,12-bis[2-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)-3-hydroxyphenoxy]ethyl]dodecanedioate, 2,4,6-tris(2-hydroxy-4-hexyloxy-3-methylphenyl)-1,3,5-triazine, and 1,12-bis[2-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)-3-hydroxyphenoxy]ethyl]dodecanedioate; and various metal salts or metal chelates, particularly nickel and chromium salts or chelates.

[0067] Examples of fatty acid metal salts include metal salts of fatty acids having 12 to 30 carbon atoms and containing linear or branched fatty acid residues. Examples of metal ions constituting fatty acid metal salts include sodium ions, potassium ions, lithium ions, dihydroxyaluminum ions, calcium ions, zinc ions, barium ions, magnesium ions, and hydroxyaluminum ions, with sodium ions, potassium ions, lithium ions, and calcium ions being preferred. Examples of fatty acids constituting fatty acid metal salts include lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, linoleic acid, linolenic acid, arachidic acid, arachidonic acid, behenic acid, lignoceric acid, cerotic acid, montanic acid, and melissic acid, with myristic acid and stearic acid being preferred. The fatty acids constituting fatty acid metal salts may be those in which one or more hydrogen atoms of the fatty acid residue have been substituted with hydroxyl groups. Examples of such fatty acids include 12-hydroxystearic acid and 12-hydroxyoleic acid.

[0068] Examples of flame retardants include triphenyl phosphate, tricresyl phosphate, trixylenyl phosphate, cresyl diphenyl phosphate, cresyl-2,6-dixylenyl phosphate, resorcinol bis(diphenyl phosphate), (1-methylethylidene)-4,1-phenylenetetraphenyl diphosphate, 1,3-phenylenetetrakis(2,6-dimethylphenyl)phosphate, and products under the trade names "ADEKA STAB FP-500," "ADEKA STAB FP-600," and "ADEKA STAB FP-600" manufactured by ADEKA Corporation. Aromatic phosphate esters such as "Stab FP-800", phosphonate esters such as divinyl phenylphosphonate, diallyl phenylphosphonate, and 1-butenyl phenylphosphonate, phosphinate esters such as phenyl diphenylphosphinate, methyl diphenylphosphinate, and 9,10-dihydro-9-oxa-10-phosphaphenanthrene-10-oxide derivatives, phosphazene compounds such as bis(2-allylphenoxy)phosphazene and dicresylphosphazene, melamine phosphate, melamine pyrophosphate, and melamine polyphosphate amine, melam polyphosphate, ammonium polyphosphate, piperazine phosphate, piperazine pyrophosphate, piperazine polyphosphate, phosphorus-containing vinylbenzyl compounds, red phosphorus and other phosphorus-based flame retardants, magnesium hydroxide, aluminum hydroxide and other metal hydroxides, brominated bisphenol A type epoxy resin, brominated phenol novolac type epoxy resin, hexabromobenzene, pentabromotoluene, ethylene bis(pentabromophenyl), ethylene bistetrabromophthalimide, 1,2-dibromo-4-(1,2-dibromoethylene) Examples of suitable flame retardants include brominated flame retardants such as 2,4,6-tris(tribromophenoxy)-1,3,5-triazine, tribromophenylmaleimide, tribromophenyl acrylate, tribromophenyl methacrylate, tetrabromobisphenol A dimethacrylate, pentabromobenzyl acrylate, and brominated styrene. These flame retardants are preferably used in combination with anti-drip agents such as fluororesins, and flame retardant assistants such as polyhydric alcohols and hydrotalcite.

[0069] Examples of fillers include talc, mica, calcium carbonate, calcium oxide, calcium hydroxide, magnesium carbonate, magnesium hydroxide, magnesium oxide, magnesium sulfate, aluminum hydroxide, barium sulfate, glass powder, glass fiber, clay, dolomite, silica, alumina, potassium titanate whiskers, wollastonite, and fibrous magnesium oxysulfate. The particle size (fiber diameter, fiber length, and aspect ratio for fibrous fillers) can be appropriately selected. Among these fillers, talc is particularly preferred because of its excellent rigidity-imparting effect and easy availability. Furthermore, the filler may be surface-treated as needed.

[0070] Examples of lubricants include fatty acid esters such as fatty acid methyl, fatty acid ethyl, ethylene glycol fatty acid monoesters, propylene glycol fatty acid monoesters, ethylene glycol fatty acid diesters, propylene glycol fatty acid diesters, glycerol fatty acid monoesters, glycerol fatty acid diesters, glycerol fatty acid triesters, pentaerythritol fatty acid monoesters, pentaerythritol fatty acid diesters, pentaerythritol fatty acid triesters, and pentaerythritol fatty acid tetraesters; fatty acid amides such as fatty acid monoamides, alkylenebisfatty acid amides, alkylol fatty acid amides, and N-alkyl fatty acid amides; fatty acids such as lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, linoleic acid, linolenic acid, arachidic acid, arachidonic acid, behenic acid, erucic acid, lignoceric acid, cerotic acid, montanic acid, melissic acid, 12-hydroxystearic acid, and ricinoleic acid; higher alcohols such as stearyl alcohol; and sugar alcohols such as mannitol.

[0071] Examples of hydrotalcites include complex salt compounds containing magnesium, aluminum, hydroxyl groups, carbonate groups, and optional crystal water, and these may be natural or synthetic. The crystal structure, particle shape, and particle size of the hydrotalcites are not particularly limited. Furthermore, the hydrotalcites may have at least a portion of the magnesium or aluminum substituted with another metal such as an alkali metal or zinc, or at least a portion of the hydroxyl groups or carbonate groups substituted with another anion group. Furthermore, the hydrotalcites may have their crystal water dehydrated, and the surface may be coated with a higher fatty acid such as stearic acid, a higher fatty acid metal salt such as an alkali metal oleate, an organic sulfonic acid metal salt such as an alkali metal dodecylbenzenesulfonate, a higher fatty acid amide, a higher fatty acid ester, or a wax.

[0072] Examples of antistatic agents include low-molecular-weight antistatic agents such as nonionic, anionic, cationic, or amphoteric surfactants, and polymeric antistatic agents such as polymeric compounds. Nonionic surfactants include polyethylene glycol-based nonionic surfactants such as higher alcohol ethylene oxide adducts, fatty acid ethylene oxide adducts, higher alkylamine ethylene oxide adducts, and polyolefin glycol ethylene oxide adducts; polyhydric alcohol-based nonionic surfactants such as polyethylene oxide, glycerin fatty acid esters, pentaerythritol fatty acid esters, sorbitol or sorbitan fatty acid esters, polyhydric alcohol alkyl ethers, and alkanolamine fatty amides. Examples of anionic surfactants include carboxylates such as alkali metal salts of higher fatty acids; sulfate ester salts such as higher alcohol sulfate ester salts and higher alkyl ether sulfate ester salts; sulfonates such as alkylbenzene sulfonates, alkyl sulfonates, and paraffin sulfonates; and phosphate ester salts such as higher alcohol phosphate ester salts. Examples of cationic surfactants include quaternary ammonium salts such as alkyltrimethylammonium salts. Examples of amphoteric surfactants include amino acid-type amphoteric surfactants such as higher alkylaminopropionates, and betaine-type amphoteric surfactants such as higher alkyldimethylbetaine and higher alkyldihydroxyethylbetaine. Among these, anionic surfactants are preferred, and sulfonates such as alkylbenzenesulfonates, alkylsulfonates, and paraffin sulfonates are particularly preferred.

[0073] Examples of polymeric antistatic agents include ionomers and block polymers having polyethylene glycol as a hydrophilic moiety. Examples of ionomers include the ionomer described in JP 2010-132927 A. Examples of polymers having polyethylene glycol as a hydrophilic moiety include polyether ester amide described in JP 7-10989 A, polymers composed of polyolefin and polyethylene glycol described in U.S. Pat. No. 6,552,131 A, and polymers composed of polyester and polyethylene glycol described in JP 2016-023254 A.

[0074] Fluorescent brighteners are compounds that absorb ultraviolet light from sunlight or artificial light, convert it into violet-blue visible light, and radiate it to enhance the whiteness and blueness of molded articles through their fluorescent effect. Examples of fluorescent brighteners include the benzoxazole-based compound CI Fluorescent Brightener 184, the coumarin-based compound CI Fluorescent Brightener 52, and the diaminostilbene disulfonic acid-based compounds CI Fluorescent Brighteners 24, 85, and 71.

[0075] Furthermore, the nucleating agent composition of the present embodiment may be a one-pack nucleating agent composition that is further blended with a granulation aid such as a binder, a wax, a solvent, silica, etc. Furthermore, the nucleating agent composition of the present embodiment may be a masterbatch that further contains a resin component.

[0076] In the nucleating agent composition of this embodiment, the content of the triazine derivative relative to the entire nucleating agent composition can be, for example, 10 to 100% by mass, preferably 20 to 100% by mass, more preferably 40 to 100% by mass, even more preferably 60 to 100% by mass, and even more preferably 80 to 100% by mass.

[0077] Next, the resin composition of this embodiment will be described. <Resin composition> The resin composition of this embodiment contains a crystalline resin and the triazine derivative described above, and has excellent properties such as mechanical properties and transparency.

[0078] (crystalline resin) The crystalline resin contained in the resin composition of this embodiment is not particularly limited, and examples of the crystalline resin include polyolefin resins, polyamide resins, polyester resins, polyacetal resins, polylactic acid, and polyphenylene sulfide. The crystalline resin may be contained alone or in combination of two or more. Furthermore, the crystalline resin may be a copolymer or a polymer alloy.

[0079] The crystalline resin preferably includes a polyolefin resin. Examples of polyolefin resins include polyethylene resins such as low-density polyethylene, linear low-density polyethylene, high-density polyethylene, cross-linked polyethylene, and ultra-high molecular weight polyethylene; polypropylene resins such as homopolypropylene, random copolymer polypropylene, block copolymer polypropylene, impact copolymer polypropylene, high-impact copolymer polypropylene, and maleic anhydride-modified polypropylene; α-olefin polymers such as polybutene-1, cycloolefin polymer, poly-3-methyl-1-butene, poly-3-methyl-1-pentene, and poly-4-methyl-1-pentene; and α-olefin copolymers such as ethylene-methyl methacrylate copolymer and ethylene-vinyl acetate copolymer. The molecular weight, degree of polymerization, density, softening point, proportion of insoluble matter in solvent, degree of stereoregularity, presence or absence of catalyst residue, type and blending ratio of raw material monomers, and type of catalyst used in polymerization (e.g., Ziegler catalyst, metallocene catalyst, etc.) of the polyolefin resin are not particularly limited and may be selected appropriately.

[0080] In the resin composition of this embodiment, the crystalline resin preferably comprises at least one selected from the group consisting of polyethylene-based resins and polypropylene-based resins, and more preferably comprises a polypropylene-based resin. In the resin composition of this embodiment, the crystalline resin preferably comprises a random copolymer polypropylene or a homopolypropylene. In the resin composition of this embodiment, the crystalline resin may also comprise a polyethylene-based resin. When the crystalline resin comprises a polyethylene-based resin, examples of the polyethylene-based resin include low-density polyethylene, linear low-density polyethylene, high-density polyethylene, cross-linked polyethylene, and ultra-high molecular weight polyethylene. Among these, low-density polyethylene and linear low-density polyethylene are preferred, and linear low-density polyethylene is more preferred. In the resin composition of this embodiment, the crystalline resin may also comprise at least one selected from the group consisting of polyamide-based resins, polyester-based resins, polyacetal resins, polylactic acid, and polyphenylene sulfide. Preferably, the crystalline resin comprises at least one selected from the group consisting of polyamide-based resins and polyester-based resins, and more preferably, the crystalline resin comprises a polyamide-based resin. In the resin composition of the present embodiment, the crystalline resin preferably contains a polyester resin.

[0081] The resin composition of this embodiment may contain a resin other than the crystalline resin as a resin component. Examples of resins other than the crystalline resin include amorphous thermoplastic resins such as polycarbonate resins, styrene resins, acrylic resins, urethane resins, halogen-containing resins, petroleum resins, coumarone resins, polyvinyl alcohol, polyvinyl acetate, and polyphenylene oxide, as well as thermosetting resins such as phenolic resins, urea resins, melamine resins, epoxy resins, unsaturated polyester resins, and synthetic rubber. In the resin composition of this embodiment, the content of the crystalline resin relative to the total resin components contained in the resin composition is not particularly limited and may be, for example, 5 to 100% by mass. From the perspective of obtaining a resin composition with even better properties, the content of the crystalline resin relative to the total resin components contained in the resin composition is preferably 50 to 100% by mass, more preferably 80 to 100% by mass, even more preferably 90 to 100% by mass, even more preferably 95 to 100% by mass, and particularly preferably 100% by mass.

[0082] The resin composition of this embodiment may contain an elastomer as a resin component. In this case, molded articles made from the resin composition will have excellent impact resistance. Examples of elastomers include synthetic rubbers such as isoprene rubber, butadiene rubber, acrylonitrile-butadiene copolymer rubber, styrene-butadiene copolymer rubber, fluororubber, and silicone rubber, as well as thermoplastic elastomers such as polyolefin-based thermoplastic elastomers, polystyrene-based thermoplastic elastomers, polyvinyl chloride-based thermoplastic elastomers, polyurethane-based thermoplastic elastomers, polyester-based thermoplastic elastomers, and polyamide-based thermoplastic elastomers. Among these, thermoplastic elastomers are preferred from the viewpoints of improving the processability of the resin composition and reducing the weight of molded articles made from the resin composition. Furthermore, among thermoplastic elastomers, polyolefin-based thermoplastic elastomers are particularly preferred. When the resin composition of the present embodiment contains an elastomer, the content ratio of the elastomer relative to all the resin components contained in the resin composition is not particularly limited and can be, for example, 1 to 50 mass %. From the viewpoint of achieving both impact resistance and rigidity in a molded article made from the resin composition, the content ratio is preferably 5 to 30 mass %, and more preferably 10 to 25 mass %.

[0083] From the viewpoint of obtaining a resin composition having even more excellent properties, the triazine derivative in the resin composition of this embodiment is preferably one represented by the above-mentioned general formula (1). Also, from the viewpoint of obtaining a resin composition having even more excellent properties, the triazine derivative in the resin composition of this embodiment may be one represented by the above-mentioned general formula (2) or general formula (3).

[0084] In the resin composition of this embodiment, the content of the triazine derivative can be, for example, 0.001 to 10 parts by mass relative to 100 parts by mass of the crystalline resin. From the viewpoint of obtaining a resin composition with even better properties and sufficiently suppressing bleeding of the triazine derivative, the content of the triazine derivative is preferably 0.002 to 5 parts by mass relative to 100 parts by mass of the crystalline resin, more preferably 0.003 to 3 parts by mass, even more preferably 0.005 to 1 part by mass, still more preferably 0.01 to 0.5 parts by mass, even more preferably 0.02 to 0.2 parts by mass, and particularly preferably 0.03 to 0.1 parts by mass.

[0085] The resin composition of this embodiment may contain only one type of triazine derivative, or may contain two or more types. When the resin composition of this embodiment contains two or more triazine derivatives, the triazine derivative with the highest content contained in the resin composition is defined as the "main component." The content of the main component relative to the total triazine derivatives can be, for example, 10 to 99.9 mass%. From the viewpoint of obtaining a resin composition with even better properties, the content of the main component relative to the total triazine derivatives is preferably 50 to 99 mass%, more preferably 80 to 95 mass%. Note that when the resin composition of this embodiment contains two or more triazine derivatives, when the triazine derivatives contained in the resin composition other than the main component are defined as "minor components," the total content of the minor components relative to the total triazine derivatives can be, for example, 0.1 to 90 mass%. From the viewpoint of obtaining a resin composition with even better properties, the total content of the minor components relative to the total triazine derivatives can be, for example, 0.1 to 90 mass%. From the viewpoint of obtaining a resin composition with even better properties, the total content of the minor components relative to the total triazine derivatives can be, for example, 1 to 50 mass%, more preferably 5 to 20 mass%.

[0086] The resin composition of the present embodiment may further contain one or more of the other additives exemplified as components that may be contained in the nucleating agent composition described above.

[0087] Next, a method for producing the resin composition of this embodiment will be described. <Method of manufacturing resin composition> The method for producing the resin composition of this embodiment includes a compounding step of mixing a crystalline resin with the triazine derivative described above.

[0088] The method for mixing the crystalline resin and the triazine derivative in the blending step is not particularly limited. Examples include a method in which the triazine derivative is added to the crystalline resin and then mixed using a mixer such as an FM mixer, mill roll, Banbury mixer, or super mixer. When two or more triazine derivatives are added, the compounds may be added sequentially or all at once. The triazine derivative may also be added as the nucleating agent composition described above. Furthermore, in the blending step, one or more of a colorant and the other additives described above may also be blended. Furthermore, the method for producing a resin composition according to this embodiment may further include, in addition to the blending step described above, a melt-kneading step in which the mixture obtained in the blending step is melt-kneaded using a melt-kneading device such as a single-screw extruder or a twin-screw extruder. The melt-kneading temperature in the melt-kneading step may be, for example, 180 to 280°C. The method for producing a resin composition according to this embodiment may also include a granulation step in which the mixture obtained in the melt-kneading step is granulated. Here, the granulation method is not particularly limited, and examples thereof include a method using a granulation device such as a pelletizer. The shape of the resin composition obtained by granulation is also not particularly limited, and it can be, for example, pelletized. Furthermore, the method for producing the resin composition of this embodiment may be a method in which the triazine derivative and, if necessary, a colorant and one or more of the other additives described above are added before or during polymerization of the crystalline resin monomer or oligomer, and the remaining components are added to the resulting polymer.

[0089] Next, the molded product of this embodiment will be described. <Molded products> The molded article of this embodiment is obtained by molding the above-described resin composition.

[0090] Examples of molded articles include injection molded articles, fibers, flat yarns, biaxially oriented films, uniaxially oriented films, unoriented films, sheets, thermoforming molded articles, extrusion blow molded articles, injection blow molded articles, injection stretch blow molded articles, profile extrusion molded articles, rotational molded articles, etc. Preferred specific examples of molded articles include containers such as bottles, jars, cups, buckets, boxes, cans, and tanks.

[0091] The method for producing the molded article is not particularly limited, and examples thereof include injection molding, extrusion molding, blow molding, rotational molding, vacuum molding, inflation molding, calendar molding, slush molding, dip molding, and thermoforming.

[0092] Next, the method for improving the crystallinity of the crystalline resin according to this embodiment will be described. <Method for improving the crystallinity of crystalline resin> The method for improving the crystallinity of a crystalline resin according to this embodiment includes a blending step of mixing a crystalline resin with the triazine derivative described above.

[0093] According to the method for improving the crystallinity of a crystalline resin of this embodiment, the crystallinity of the crystalline resin can be improved.

[0094] Other embodiments of the present invention include the following. [1] A triazine derivative represented by the following general formula (1): JPEG2025160482000013.jpg27147 (In general formula (1), X1, X2, and X3 each independently represent a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, a substituted or unsubstituted arylamino group, or a substituted or unsubstituted arylthio group.) [2] The triazine derivative according to [1], wherein X1, X2 and X3 in general formula (1) are each independently a substituted or unsubstituted aryl group. [3] The triazine derivative according to [1], wherein X1, X2 and X3 in general formula (1) each independently represent a substituted or unsubstituted arylalkyl group. [4] The triazine derivative according to [1], wherein X1, X2 and X3 in general formula (1) are each independently a substituted or unsubstituted arylamino group. [5] The triazine derivative according to [1], wherein X1, X2 and X3 in general formula (1) are each independently a substituted or unsubstituted arylthio group. [6] A triazine derivative represented by general formula (2): JPEG2025160482000014.jpg27147 (In general formula (2), X4 represents a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, a substituted or unsubstituted arylamino group, or a substituted or unsubstituted arylthio group, and Y1 represents a substituted or unsubstituted arylene group, a substituted or unsubstituted arylene dialkylene group, a substituted or unsubstituted arylene diamino group, or a substituted or unsubstituted arylene dithio group.) [7] The triazine derivative according to [6], wherein X4 in general formula (2) is a substituted or unsubstituted aryl group, and Y1 is a substituted or unsubstituted arylene group. [8] The triazine derivative according to [6], wherein X4 in the general formula (2) is a substituted or unsubstituted arylalkyl group, and Y1 is a substituted or unsubstituted arylene dialkylene group. [9] The triazine derivative according to [6], wherein X4 in general formula (2) is a substituted or unsubstituted arylamino group, and Y1 is a substituted or unsubstituted arylenediamino group.

[10] The triazine derivative according to [6], wherein X4 in general formula (2) is a substituted or unsubstituted arylthio group, and Y1 is a substituted or unsubstituted arylenedithio group.

[11] A triazine derivative represented by general formula (3): JPEG2025160482000015.jpg24147 (In general formula (3), X5 and X6 each independently represent a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, a substituted or unsubstituted arylamino group, or a substituted or unsubstituted arylthio group; and Y2 represents a substituted or unsubstituted arylene group, a substituted or unsubstituted arylene dialkylene group, a substituted or unsubstituted arylene diamino group, or a substituted or unsubstituted arylene dithio group.)

[12]

[11] The triazine derivative according to

[11] , wherein X5 and X6 in general formula (3) each independently represent a substituted or unsubstituted aryl group, and Y2 represents a substituted or unsubstituted arylene group.

[13]

[11] The triazine derivative according to

[11] , wherein X5 and X6 in general formula (3) each independently represent a substituted or unsubstituted arylalkyl group, and Y2 represents a substituted or unsubstituted arylene dialkylene group.

[14]

[11] The triazine derivative according to

[11] , wherein X5 and X6 in general formula (3) each independently represent a substituted or unsubstituted arylamino group, and Y2 represents a substituted or unsubstituted arylenediamino group.

[15]

[11] The triazine derivative according to

[11] , wherein X5 and X6 in general formula (3) each independently represent a substituted or unsubstituted arylthio group, and Y2 represents a substituted or unsubstituted arylenedithio group.

[16] A nucleating agent composition comprising the triazine derivative according to any one of [1] to

[15] .

[17]

[16] The nucleating agent composition according to

[16] , further comprising a colorant.

[18]

[17] The nucleating agent composition according to

[17] , wherein the colorant is a green pigment, a blue pigment, or a purple pigment, preferably a blue pigment or a purple pigment, more preferably a blue pigment.

[19] The nucleating agent composition according to

[17] or

[18] , wherein the content of the colorant is 0.01 to 5 parts by mass, preferably 0.1 to 2 parts by mass, more preferably 0.3 to 1.5 parts by mass, and even more preferably 0.5 to 1 part by mass, relative to 100 parts by mass of the triazine derivative.

[20] a crystalline resin; a triazine derivative according to any one of [1] to [5]; A resin composition comprising: [twenty one] a crystalline resin; a triazine derivative according to any one of [6] to

[10] ; A resin composition comprising: [twenty two] a crystalline resin; a triazine derivative according to any one of

[11] to

[15] ; A resin composition comprising: [twenty three] The resin composition according to any one of

[20] to

[22] , wherein the crystalline resin comprises at least one selected from the group consisting of polyolefin resins, polyamide resins, polyester resins, polyacetal resins, polylactic acid, and polyphenylene sulfide. [twenty four] The resin composition according to any one of

[20] to

[22] , wherein the crystalline resin comprises a polyolefin-based resin. [twenty five] The resin composition according to any one of

[20] to

[22] , wherein the crystalline resin comprises a polypropylene-based resin.

[26] The resin composition according to any one of

[20] to

[22] , wherein the crystalline resin comprises a polyethylene resin.

[27] The resin composition according to any one of

[20] to

[22] , wherein the crystalline resin comprises a polyamide resin.

[28] The resin composition according to any one of

[20] to

[22] , wherein the crystalline resin comprises a polyester-based resin.

[29] A molded article obtained by molding the resin composition according to any one of

[20] to

[28] .

[30] Crystalline resin and a triazine derivative according to any one of [1] to

[15] ; A method for producing a resin composition, comprising a compounding step of mixing the above components.

[31] a crystalline resin; a triazine derivative according to any one of [1] to

[15] ; A method for improving the crystallinity of a crystalline resin, comprising a compounding step of mixing the above.

[0095] The present invention is not limited to the above-described embodiments. The above-described embodiments are merely examples, and anything that has substantially the same configuration as the technical idea described in the claims of the present invention and that exhibits similar effects is included within the technical scope of the present invention. [Example]

[0096] The present invention will be explained in more detail below by way of examples, but the present invention is not limited to the following examples in any way.

[0097] (triazine compounds) Examples of the triazine compound of the present invention include Compounds 1-1 to 1-51, Compounds 2-1 to 2-138, and Compounds 3-1 to 3-12. (Nucleating agent composition) Examples of nucleating agent compositions of the present invention include the following:

[0098] Nucleating agent compositions 1 to 201: Nucleating agent compositions each comprising one compound selected from the above Compounds 1-1 to 1-51, Compounds 2-1 to 2-138, and Compounds 3-1 to 3-12.

[0099] Nucleating agent compositions 202 to 402: Nucleating agent compositions obtained by blending 0.5 parts by mass of Pigment Blue 27 with 100 parts by mass of one compound selected from the above Compounds 1-1 to 1-51, Compounds 2-1 to 2-138, and Compounds 3-1 to 3-12, and mixing the mixture uniformly.

[0100] Nucleating agent compositions 403 to 603: Nucleating agent compositions obtained by blending 1 part by mass of Pigment Blue 27 with 100 parts by mass of one compound selected from the above Compounds 1-1 to 1-51, Compounds 2-1 to 2-138, and Compounds 3-1 to 3-12, and mixing them uniformly.

[0101] Nucleating agent compositions 604 to 804: Nucleating agent compositions obtained by blending 0.5 parts by mass of Pigment Blue 29 with 100 parts by mass of one compound selected from the above Compounds 1-1 to 1-51, Compounds 2-1 to 2-138, and Compounds 3-1 to 3-12, and mixing the resulting mixture uniformly.

[0102] Nucleating agent compositions 805 to 1005: Nucleating agent compositions obtained by blending 1 part by mass of Pigment Blue 29 with 100 parts by mass of one compound selected from the above Compounds 1-1 to 1-51, Compounds 2-1 to 2-138, and Compounds 3-1 to 3-12, and mixing the resulting mixture uniformly.

[0103] Nucleating agent compositions 1006 to 1206: Nucleating agent compositions obtained by blending 0.5 parts by mass of Acid Blue 74 with 100 parts by mass of one compound selected from the above Compounds 1-1 to 1-51, Compounds 2-1 to 2-138, and Compounds 3-1 to 3-12, and mixing the mixture uniformly.

[0104] Nucleating agent compositions 1207 to 1407: Nucleating agent compositions obtained by blending 1 part by mass of Acid Blue 74 with 100 parts by mass of one compound selected from the above Compounds 1-1 to 1-51, Compounds 2-1 to 2-138, and Compounds 3-1 to 3-12, and mixing the mixture uniformly.

[0105] Nucleating agent compositions 1408 to 1608: Nucleating agent compositions obtained by blending 0.5 parts by mass of Acid Blue 9 with 100 parts by mass of one compound selected from the above Compounds 1-1 to 1-51, Compounds 2-1 to 2-138, and Compounds 3-1 to 3-12, and mixing the mixture uniformly.

[0106] Nucleating agent compositions 1609 to 1809: Nucleating agent compositions obtained by blending 1 part by mass of Acid Blue 9 with 100 parts by mass of one compound selected from the above Compounds 1-1 to 1-51, Compounds 2-1 to 2-138, and Compounds 3-1 to 3-12, and mixing the mixture uniformly.

[0107] Nucleating agent compositions 1809 to 2010: Nucleating agent compositions obtained by blending 0.5 parts by mass of Pigment Violet 15 with 100 parts by mass of one compound selected from the above Compounds 1-1 to 1-51, Compounds 2-1 to 2-138, and Compounds 3-1 to 3-12, and mixing the mixture uniformly.

[0108] Nucleating agent compositions 2011 to 2211: Nucleating agent compositions obtained by blending 1 part by mass of Pigment Violet 15 with 100 parts by mass of one compound selected from the above Compounds 1-1 to 1-51, Compounds 2-1 to 2-138, and Compounds 3-1 to 3-12, and mixing the mixture uniformly.

[0109] (Resin composition) Examples of the resin composition of this embodiment include the following.

[0110] 100 parts by mass of homopolypropylene (MFR=8g / 10min at 230°C and 2.16kg load) was blended with 0.05 parts by mass of tetrakis[methylene-3-(3',5'-tert-butyl-4'-hydroxyphenyl)propionate]methane, 0.1 parts by mass of tris(2,4-di-tert-butylphenyl)phosphite, 0.05 parts by mass of calcium stearate, and 0.2 parts by mass of one of Nucleating Agent Compositions 1 to 2211, and mixed at 1000 rpm for 1 minute using an FM mixer (FM200 manufactured by Mitsui Mining Co., Ltd.). The resulting mixture was then fed into a twin-screw extruder (TEX-28V manufactured by The Japan Steel Works, Ltd.) and melt-kneaded at a melt temperature of 230°C and a screw speed of 150 rpm. The resulting pellets were then dried at 60°C for 8 hours to obtain a resin composition.

[0111] 100 parts by mass of homopolypropylene (MFR=8g / 10min at 230°C and 2.16kg load) was blended with 0.05 parts by mass of tetrakis[methylene-3-(3',5'-tert-butyl-4'-hydroxyphenyl)propionate]methane, 0.1 parts by mass of tris(2,4-di-tert-butylphenyl)phosphite, 0.05 parts by mass of calcium stearate, and 0.5 parts by mass of one of Nucleating Agent Compositions 1 to 2211. The mixture was mixed at 1000 rpm for 1 minute using an FM mixer (FM200 manufactured by Mitsui Mining Co., Ltd.), and the resulting mixture was fed into a twin-screw extruder (TEX-28V manufactured by The Japan Steel Works, Ltd.), melt-kneaded at a melt temperature of 230°C and a screw speed of 150 rpm. The resulting pellets were then dried at 60°C for 8 hours to obtain a resin composition.

[0112] 100 parts by mass of homopolypropylene (MFR=8g / 10min at 230°C and 2.16kg load) was blended with 0.05 parts by mass of tetrakis[methylene-3-(3',5'-tert-butyl-4'-hydroxyphenyl)propionate]methane, 0.1 parts by mass of tris(2,4-di-tert-butylphenyl)phosphite, 0.05 parts by mass of calcium stearate, and 1 part by mass of one of Nucleating Agent Compositions 1 to 2211. The blend was mixed at 1000 rpm for 1 minute using an FM mixer (FM200 manufactured by Mitsui Mining Co., Ltd.). The resulting mixture was then fed into a twin-screw extruder (TEX-28V manufactured by The Japan Steel Works, Ltd.) and melt-kneaded at a melt temperature of 230°C and a screw speed of 150 rpm. The resulting pellets were then dried at 60°C for 8 hours to obtain a resin composition.

[0113] A resin composition was prepared by blending 100 parts by mass of random copolymer polypropylene (MFR = 12 g / 10 min at 230°C and a load of 2.16 kg, manufactured by Prime Polymer Co., Ltd. under the trade name "Prime Polypro R720") with 0.05 parts by mass of tetrakis[methylene-3-(3',5'-tert-butyl-4'-hydroxyphenyl)propionate]methane, 0.1 parts by mass of tris(2,4-di-tert-butylphenyl)phosphite, 0.05 parts by mass of calcium stearate, and 0.2 parts by mass of one of Nucleating Agent Compositions 1 to 2211 using an FM Mixer (FM200 manufactured by Mitsui Mining Co., Ltd.) at 1000 rpm for 1 minute. The resulting mixture was then fed into a twin-screw extruder (TEX-28V manufactured by The Japan Steel Works, Ltd.) and melt-kneaded at a melt temperature of 230°C and a screw speed of 150 rpm. The resulting pellets were then dried at 60°C for 8 hours to obtain the resin composition.

[0114] A resin composition was prepared by blending 100 parts by mass of random copolymer polypropylene (MFR = 12 g / 10 min at 230°C and a load of 2.16 kg, manufactured by Prime Polymer Co., Ltd. under the trade name "Prime Polypro R720") with 0.05 parts by mass of tetrakis[methylene-3-(3',5'-tert-butyl-4'-hydroxyphenyl)propionate]methane, 0.1 parts by mass of tris(2,4-di-tert-butylphenyl)phosphite, 0.05 parts by mass of calcium stearate, and 0.5 parts by mass of one of Nucleating Agent Compositions 1 to 2211 using an FM Mixer (FM200 manufactured by Mitsui Mining Co., Ltd.) at 1000 rpm for 1 minute. The resulting mixture was then fed into a twin-screw extruder (TEX-28V manufactured by The Japan Steel Works, Ltd.) and melt-kneaded at a melt temperature of 230°C and a screw speed of 150 rpm. The resulting pellets were then dried at 60°C for 8 hours to obtain the resin composition.

[0115] A resin composition was prepared by blending 100 parts by mass of random copolymer polypropylene (MFR = 12 g / 10 min at 230°C and a load of 2.16 kg, manufactured by Prime Polymer Co., Ltd. under the trade name "Prime Polypro R720") with 0.05 parts by mass of tetrakis[methylene-3-(3',5'-tert-butyl-4'-hydroxyphenyl)propionate]methane, 0.1 parts by mass of tris(2,4-di-tert-butylphenyl)phosphite, 0.05 parts by mass of calcium stearate, and 1 part by mass of one of Nucleating Agent Compositions 1 to 2211 using an FM Mixer (FM200 manufactured by Mitsui Mining Co., Ltd.) at 1000 rpm for 1 minute. The resulting mixture was then fed into a twin-screw extruder (TEX-28V manufactured by The Japan Steel Works, Ltd.) and melt-kneaded at a melt temperature of 230°C and a screw speed of 150 rpm. The resulting pellets were then dried at 60°C for 8 hours to obtain the resin composition.

[0116] 100 parts by mass of low-density polyethylene (MFR = 2.4 g / 10 min at 190°C and a load of 2.16 kg, product name "NUC-8160" manufactured by ENEOS NUC Corporation) was blended with 0.05 parts by mass of tetrakis[methylene-3-(3',5'-tert-butyl-4'-hydroxyphenyl)propionate]methane, 0.1 parts by mass of tris(2,4-di-tert-butylphenyl)phosphite, 0.05 parts by mass of calcium stearate, and 0.2 parts by mass of one of Nucleating Agent Compositions 1 to 2211. The resulting mixture was mixed uniformly and placed in a twin-screw extruder (Labo Plastomill Micro manufactured by Toyo Seiki Seisaku-sho, Ltd.), melt-kneaded at a melt temperature of 210°C and a screw speed of 100 rpm, and then granulated. The resulting pellets were dried at 60°C for 8 hours to obtain a resin composition.

[0117] A resin composition was prepared by blending 100 parts by mass of low-density polyethylene (MFR = 2.4 g / 10 min at 190°C and a load of 2.16 kg, product name "NUC-8160" manufactured by ENEOS NUC) with 0.05 parts by mass of tetrakis[methylene-3-(3',5'-tert-butyl-4'-hydroxyphenyl)propionate]methane, 0.1 parts by mass of tris(2,4-di-tert-butylphenyl)phosphite, 0.05 parts by mass of calcium stearate, and 0.5 parts by mass of one of Nucleating Agent Compositions 1 to 2211, and mixing the mixture uniformly. The resulting mixture was then loaded into a twin-screw extruder (Labo Plastomill Micro manufactured by Toyo Seiki Seisakusho), melt-kneaded at a melt temperature of 210°C and a screw speed of 100 rpm, and the resulting pellets were dried at 60°C for 8 hours.

[0118] A resin composition was prepared by blending 100 parts by mass of low-density polyethylene (MFR=2.4g / 10min at 190°C and a load of 2.16kg, product name "NUC-8160" manufactured by ENEOS NUC) with 0.05 parts by mass of tetrakis[methylene-3-(3',5'-tert-butyl-4'-hydroxyphenyl)propionate]methane, 0.1 parts by mass of tris(2,4-di-tert-butylphenyl)phosphite, 0.05 parts by mass of calcium stearate, and 1 part by mass of one of Nucleating Agent Compositions 1 to 2211, and mixing the mixture uniformly. The resulting mixture was then loaded into a twin-screw extruder (Labo Plastomill Micro manufactured by Toyo Seiki Seisaku-sho, Ltd.) and melt-kneaded at a melt temperature of 210°C and a screw speed of 100 rpm. The resulting pellets were then dried at 60°C for 8 hours to obtain the resin composition.

[0119] A resin composition was prepared by blending 100 parts by mass of linear low-density polyethylene (C4LLDPE, MFR = 5.0 g / 10 min at 190°C and a load of 2.16 kg, product name "Novatec UR952G" manufactured by Japan Polyethylene Corporation) with 0.05 parts by mass of tetrakis[methylene-3-(3',5'-tert-butyl-4'-hydroxyphenyl)propionate]methane, 0.1 parts by mass of tris(2,4-di-tert-butylphenyl)phosphite, 0.05 parts by mass of calcium stearate, and 0.2 parts by mass of one of Nucleating Agent Compositions 1 to 2211, and mixing the mixture uniformly. The resulting mixture was then loaded into a twin-screw extruder (Labo Plastomill Micro manufactured by Toyo Seiki Seisaku-sho, Ltd.) and melt-kneaded at a melt temperature of 210°C and a screw speed of 100 rpm. The resulting pellets were then dried at 60°C for 8 hours to obtain the resin composition.

[0120] A resin composition was prepared by blending 100 parts by mass of linear low-density polyethylene (C4LLDPE, MFR = 5.0 g / 10 min at 190°C and a load of 2.16 kg, product name "Novatec UR952G" manufactured by Japan Polyethylene Corporation) with 0.05 parts by mass of tetrakis[methylene-3-(3',5'-tert-butyl-4'-hydroxyphenyl)propionate]methane, 0.1 parts by mass of tris(2,4-di-tert-butylphenyl)phosphite, 0.05 parts by mass of calcium stearate, and 0.5 parts by mass of one of Nucleating Agent Compositions 1 to 2211, and mixing the mixture uniformly. The resulting mixture was then loaded into a twin-screw extruder (Labo Plastomill Micro manufactured by Toyo Seiki Seisaku-sho, Ltd.) and melt-kneaded at a melt temperature of 210°C and a screw speed of 100 rpm. The resulting pellets were then dried at 60°C for 8 hours to obtain the resin composition.

[0121] A resin composition was prepared by blending 100 parts by mass of linear low-density polyethylene (C4LLDPE, MFR = 5.0 g / 10 min at 190°C and a load of 2.16 kg, product name "Novatec UR952G" manufactured by Japan Polyethylene Corporation) with 0.05 parts by mass of tetrakis[methylene-3-(3',5'-tert-butyl-4'-hydroxyphenyl)propionate]methane, 0.1 parts by mass of tris(2,4-di-tert-butylphenyl)phosphite, 0.05 parts by mass of calcium stearate, and 1 part by mass of one of Nucleating Agent Compositions 1 to 2211. The mixture was mixed uniformly and charged into a twin-screw extruder (Labo Plastomill Micro manufactured by Toyo Seiki Seisaku-sho, Ltd.), melt-kneaded at a melt temperature of 210°C and a screw speed of 100 rpm, and then granulating the resulting pellets, which were then dried at 60°C for 8 hours.

[0122] A resin composition was prepared by blending 100 parts by mass of linear low-density polyethylene (C6LLDPE, MFR = 2.9 g / 10 min at 190°C and a load of 2.16 kg, product name "Novatec C6 SF8402G" manufactured by Japan Polyethylene Corporation) with 0.05 parts by mass of tetrakis[methylene-3-(3',5'-tert-butyl-4'-hydroxyphenyl)propionate]methane, 0.1 parts by mass of tris(2,4-di-tert-butylphenyl)phosphite, 0.05 parts by mass of calcium stearate, and 0.2 parts by mass of one of Nucleating Agent Compositions 1 to 2211, and mixing the mixture uniformly. The resulting mixture was then fed into a twin-screw extruder (Labo Plastomill Micro manufactured by Toyo Seiki Seisaku-sho, Ltd.) and melt-kneaded at a melt temperature of 210°C and a screw speed of 100 rpm. The resulting pellets were then dried at 60°C for 8 hours to obtain the resin composition.

[0123] A resin composition was prepared by blending 100 parts by mass of linear low-density polyethylene (C6LLDPE, MFR = 2.9 g / 10 min at 190°C and a load of 2.16 kg, product name "Novatec C6 SF8402G" manufactured by Japan Polyethylene Corporation) with 0.05 parts by mass of tetrakis[methylene-3-(3',5'-tert-butyl-4'-hydroxyphenyl)propionate]methane, 0.1 parts by mass of tris(2,4-di-tert-butylphenyl)phosphite, 0.05 parts by mass of calcium stearate, and 0.5 parts by mass of one of Nucleating Agent Compositions 1 to 2211, and mixing the mixture uniformly. The resulting mixture was then fed into a twin-screw extruder (Labo Plastomill Micro manufactured by Toyo Seiki Seisaku-sho, Ltd.) and melt-kneaded at a melt temperature of 210°C and a screw speed of 100 rpm. The resulting pellets were then dried at 60°C for 8 hours to obtain the resin composition.

[0124] A resin composition was prepared by blending 100 parts by mass of linear low-density polyethylene (C6LLDPE, MFR = 2.9 g / 10 min at 190°C and a load of 2.16 kg, product name "Novatec C6 SF8402G" manufactured by Japan Polyethylene Corporation) with 0.05 parts by mass of tetrakis[methylene-3-(3',5'-tert-butyl-4'-hydroxyphenyl)propionate]methane, 0.1 parts by mass of tris(2,4-di-tert-butylphenyl)phosphite, 0.05 parts by mass of calcium stearate, and 1 part by mass of one of Nucleating Agent Compositions 1 to 2211. The mixture was mixed uniformly and charged into a twin-screw extruder (Labo Plastomill Micro manufactured by Toyo Seiki Seisaku-sho, Ltd.), melt-kneaded at a melt temperature of 210°C and a screw speed of 100 rpm, and then granulating the resulting pellets, which were then dried at 60°C for 8 hours.

[0125] 100 parts by mass of a polyolefin thermoplastic elastomer (MFR=40 g / 10 min at 230°C and a load of 10 kg, trade name "Milastomer 6030NS" manufactured by Mitsui Chemicals, Inc.) was blended with 0.05 parts by mass of tetrakis[methylene-3-(3',5'-tert-butyl-4'-hydroxyphenyl)propionate]methane, 0.1 parts by mass of tris(2,4-di-tert-butylphenyl)phosphite, 0.05 parts by mass of calcium stearate, and 0.2 parts by mass of one of Nucleating Agent Compositions 1 to 2211. The resulting mixture was mixed at 1000 rpm for 1 minute using an FM mixer (FM200 manufactured by Mitsui Mining Co., Ltd.). The resulting mixture was then extruded in a twin-screw extruder (Japan Steel Works, Ltd.). The resin composition was obtained by adding the mixture to a melting kneader (TEX-28V) and melt-kneading it at a melting temperature of 200°C and a screw speed of 150 rpm, then granulating it into pellets and drying the resulting pellets at 60°C for 8 hours.

[0126] 100 parts by mass of a polyolefin thermoplastic elastomer (MFR=40 g / 10 min at 230°C and a load of 10 kg, trade name "Milastomer 6030NS" manufactured by Mitsui Chemicals, Inc.) was blended with 0.05 parts by mass of tetrakis[methylene-3-(3',5'-tert-butyl-4'-hydroxyphenyl)propionate]methane, 0.1 parts by mass of tris(2,4-di-tert-butylphenyl)phosphite, 0.05 parts by mass of calcium stearate, and 0.5 parts by mass of one of Nucleating Agent Compositions 1 to 2211. The resulting mixture was mixed at 1000 rpm for 1 minute using an FM mixer (FM200 manufactured by Mitsui Mining Co., Ltd.). The resulting mixture was then extruded into a twin-screw extruder (Japan Steel Works, Ltd.). The resin composition was obtained by adding the mixture to a melting kneader (TEX-28V) and melt-kneading it at a melting temperature of 200°C and a screw speed of 150 rpm, then granulating it into pellets and drying the resulting pellets at 60°C for 8 hours.

[0127] 100 parts by mass of a polyolefin thermoplastic elastomer (MFR=40 g / 10 min at 230°C and a 10 kg load, manufactured by Mitsui Chemicals, Inc., trade name "Milastomer 6030NS") was blended with 0.05 parts by mass of tetrakis[methylene-3-(3',5'-tert-butyl-4'-hydroxyphenyl)propionate]methane, 0.1 parts by mass of tris(2,4-di-tert-butylphenyl)phosphite, 0.05 parts by mass of calcium stearate, and 1 part by mass of one of Nucleating Agent Compositions 1 to 2211. The blend was mixed at 1000 rpm for 1 minute using an FM mixer (FM200 manufactured by Mitsui Mining Co., Ltd.), and the resulting mixture was fed into a twin-screw extruder (TEX-28V manufactured by The Japan Steel Works, Ltd.), melt-kneaded at a melt temperature of 200°C and a screw speed of 150 rpm. The resulting pellets were then dried at 60°C for 8 hours to obtain a resin composition.

Claims

1. A triazine derivative represented by the following general formula (1): (In general formula (1), X １ , X ２ and X ３ each independently represents a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, a substituted or unsubstituted arylamino group, or a substituted or unsubstituted arylthio group.

2. X in the general formula (1) １ , X ２ and X ３ 2. The triazine derivative according to claim 1, wherein each of the groups independently represents a substituted or unsubstituted aryl group or a substituted or unsubstituted arylalkyl group.

3. X in the general formula (1) １ , X ２ and X ３ 2. The triazine derivative according to claim 1, wherein each of the groups independently represents a substituted or unsubstituted arylamino group.

4. X in the general formula (1) １ , X ２ and X ３ 2. The triazine derivative according to claim 1, wherein each of the groups independently represents a substituted or unsubstituted arylthio group.

5. A triazine derivative represented by the following general formula (2) or (3): (In general formula (2), X ４ represents a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, a substituted or unsubstituted arylamino group, or a substituted or unsubstituted arylthio group; Y １ represents a substituted or unsubstituted arylene group, a substituted or unsubstituted arylene dialkylene group, a substituted or unsubstituted arylene diamino group, or a substituted or unsubstituted arylene dithio group. (In general formula (3), X ５ and X ６ each independently represents a substituted or unsubstituted aryl group, a substituted or unsubstituted arylalkyl group, a substituted or unsubstituted arylamino group, or a substituted or unsubstituted arylthio group; Y ２ represents a substituted or unsubstituted arylene group, a substituted or unsubstituted arylene dialkylene group, a substituted or unsubstituted arylene diamino group, or a substituted or unsubstituted arylene dithio group.

6. X in the general formula (2) ４ is a substituted or unsubstituted aryl group or a substituted or unsubstituted arylalkyl group, and Y １ is a substituted or unsubstituted arylene group or a substituted or unsubstituted arylene dialkylene group, X in the general formula (3) ５ and X ６ are each independently a substituted or unsubstituted aryl group or a substituted or unsubstituted arylalkyl group, and Y ２ The triazine derivative according to claim 5, wherein is a substituted or unsubstituted arylene group or a substituted or unsubstituted arylene dialkylene group.

7. X in the general formula (2) ４ is a substituted or unsubstituted arylamino group, and Y １ is a substituted or unsubstituted arylene diamino group, X in the general formula (3) ５ and X ６ are each independently a substituted or unsubstituted arylamino group, and Y ２ The triazine derivative according to claim 5, wherein is a substituted or unsubstituted arylene diamino group.

8. X in the general formula (2) ４ is a substituted or unsubstituted arylthio group, and Y １ is a substituted or unsubstituted arylenedithio group, X in the general formula (3) ５ and X ６ are each independently a substituted or unsubstituted arylthio group, and Y ２ The triazine derivative according to claim 5, wherein is a substituted or unsubstituted arylenedithio group.

9. A nucleating agent composition comprising the triazine derivative according to any one of claims 1 to 8.

10. a crystalline resin; The triazine derivative according to any one of claims 1 to 4, A resin composition comprising:

11. a crystalline resin; The triazine derivative according to any one of claims 5 to 8, A resin composition comprising:

12. A molded article obtained by molding the resin composition according to claim 10.

13. A molded article obtained by molding the resin composition according to claim 11.

14. Crystalline resin and A triazine derivative according to any one of claims 1 to 8, A method for producing a resin composition, comprising a compounding step of mixing the above components.

15. a crystalline resin; A triazine derivative according to any one of claims 1 to 8, A method for improving the crystallinity of a crystalline resin, comprising a compounding step of mixing the above.

Images